TASK-1 potassium channels limit pancreatic α-cell calcium influx and glucagon secretion

Molecular Endocrinology

Volumn 29, Issue 5, 2015, Pages 777-787

  Dadi, Prasanna K ^a   Luo, Brooke ^b   Vierra, Nicholas C ^a   Jacobson, David A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 1899; CALCIUM; GLUCAGON; GLUCOSE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL TASK 1; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; NERVE PROTEIN; POTASSIUM CHANNEL SUBFAMILY K MEMBER 3; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; ELECTRIC ACTIVITY; GLUCAGON RELEASE; GLUCOSE TOLERANCE; HUMAN; MEMBRANE DEPOLARIZATION; MEMBRANE ELECTROPHYSIOLOGY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE; VOLTAGE CLAMP TECHNIQUE; ANIMAL; C57BL MOUSE; CALCIUM SIGNALING; CELL CULTURE; FEMALE; GENE EXPRESSION; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PHYSIOLOGY; SECRETION (PROCESS);

MUS; RODENTIA;

ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GLUCAGON; GLUCAGON-SECRETING CELLS; GLUCOSE; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN;

EID: 84930519921     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1321     Document Type: Article

References (51)

1. Müller WA, Faloona GR, Unger RH. Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med. 1973; 54(1):52-57.
2. Sherwin RS, Fisher M, Hendler R, Felig P. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med. 1976;294(9):455-461.
3. Quesada I, Tudurí E, Ripoll C, Nadal A. Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199(1):5-19.
4. Unger RH, Cherrington AD. Glucagonocentric restructuring of di abetes: a pathophysiologic and therapeutic makeover. J Clin Invest. 2012;122(1):4-12.
5. MacDonald PE, De Marinis YZ, Ramracheya R, et al. A K ATP channel-dependent pathway within α cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol. 2007;5(6):e143.
6. Quoix N, Cheng-Xue R, Mattart L, et al. Glucose and pharmacological modulators of ATP-sensitive K+ channels control [Ca2+]c by different mechanisms in isolated mouse α-cells. Diabetes. 2009; 58(2):412-421.
7. Zhang Q, Ramracheya R, Lahmann C, et al. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metab. 2013;18(6):871-882.
8. Rorsman P, Salehi SA, Abdulkader F, Braun M, MacDonald PE. K(ATP)-channels and glucose-regulated glucagon secretion. Trends Endocrinol Metab. 2008;19(8):277-284.
9. Manning Fox JE, Gyulkhandanyan AV, Satin LS, Wheeler MB. Oscillatory membrane potential response to glucose in islet β-cells: a comparison of islet-cell electrical activity in mouse and rat. Endocrinology. 2006;147(10):4655-4663.
10. Allister EM, Robson-Doucette CA, Prentice KJ, et al. UCP2 regulates the glucagon response to fasting and starvation. Diabetes. 2013;62(5):1623-1633.
11. Bokvist K, Olsen HL, Høy M, et al. Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells. Pflugers Arch. 1999;438(4):428-436.
12. -/- mouse α-cells. Diabetes. 2004;53(suppl 3):S181-S189.
13. Gopel SO, Kanno T, Barg S, Weng XG, Gromada J, Rorsman P. Regulation of glucagon release in mouse -cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol. 2000; 528(Pt 3):509-520.
14. Kang D, Choe C, Kim D. Functional expression of TREK-2 in insulin-secreting MIN6 cells. Biochem Biophys Res Commun. 2004;323(1):323-331.
15. Duprat F, Lauritzen I, Patel A, Honoré E. The TASK background K2P channels: chemo- and nutrient sensors. Trends Neurosci. 2007;30(11):573-580.
16. Hatlapatka K, Willenborg M, Rustenbeck I. Plasma membrane depolarization as a determinant of the first phase of insulin secretion. Am J Physiol Endocrinol Metab. 2009;297(2):E315-E322.
17. Ren J, Sherman A, Bertram R, et al. Slow oscillations of KATP conductance in mouse pancreatic islets provide support for electrical bursting driven by metabolic oscillations. Am J Physiol Endocrinol Metab. 2013;305(7):E805-E817.
18. Mathie A, Al-Moubarak E, Veale EL. Gating of two pore domain potassium channels. J Physiol. 2010;588(pt 17):3149-3156.
19. Benner C, van der Meulen T, Caceres E, Tigyi K, Donaldson CJ, Huising MO. The transcriptional landscape of mouse β cells compared to human β cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genom. 2014;15:620.
20. Bang H, Kim Y, Kim D. TREK-2, a new member of the mechanosensitive tandem-pore K+ channel family. J Biol Chem. 2000; 275(23):17412-17419.
21. Girard C, Duprat F, Terrenoire C, et al. Genomic and functional characteristics of novel human pancreatic 2P domain K(+) channels. Biochem Biophys Res Commun. 2001;282(1):249-256.
22. Duprat F, Lesage F, Fink M, Reyes R, Heurteaux C, Lazdunski M. TASK, a human background K+ channel to sense external pH variations near physiological pH. EMBO J. 1997;16(17):5464- 5471.
23. Bramswig NC, Everett LJ, Schug J, et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest. 2013;123(3):1275-1284.
24. Ku GM, Kim H, Vaughn IW, et al. Research resource: RNA-Seq reveals unique features of the pancreatic β-cell transcriptome. Mol Endocrinol. 2012;26(10):1783-1792.
25. Chatelain FC, Bichet D, Douguet D, et al. TWIK1, a unique background channel with variable ion selectivity. Proc Natl Acad Sci USA. 2012;109(14):5499-5504.
26. Dadi PK, Vierra NC, Jacobson DA. Pancreatic β-cell specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance. Endocrinology. 2014;155(10):3757-3768.
27. Talley EM, Lei Q, Sirois JE, Bayliss DA. TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron. 2000;25(2):399-410.
28. Sirois JE, Lei Q, Talley EM, Lynch C 3rd, Bayliss DA. The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J Neurosci. 2000;20(17):6347- 6354.
29. Streit AK, Netter MF, Kempf F, et al. A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore. J Biol Chem. 2011;286(16):13977-13984.
30. Luche H, Weber O, Nageswara Rao T, Blum C, Fehling HJ. Faithful activation of an extra-bright red fluorescent protein in “knockin” Cre-reporter mice ideally suited for lineage tracing studies. Eur J Immunol. 2007;37(1):43-53.
31. Le Marchand SJ, Piston DW. Glucose suppression of glucagon secretion: metabolic and calcium responses from α-cells in intact mouse pancreatic islets. J Biol Chem. 2010;285(19):14389-14398.
32. Herrera PL. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 2000; 127(11):2317-2322.
33. Philipson LH, Rosenberg MP, Kuznetsov A, et al. Delayed rectifier K+ channel overexpression in transgenic islets and β-cells associated with impaired glucose responsiveness. J Biol Chem. 1994; 269(45):27787-27790.
34. Rae J, Cooper K, Gates P, Watsky M. Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods. 1991;37(1):15-26.
35. Eizirik DL, Sammeth M, Bouckenooghe T, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012;8(3):e1002552.
36. Mulkey DK, Talley EM, Stornetta RL, et al. TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J Neurosci. 2007; 27(51):14049-14058.
37. Ramracheya R, Ward C, Shigeto M, et al. Membrane potentialdependent inactivation of voltage-gated ion channels in α-cells inhibits glucagon secretion from human islets. Diabetes. 2010;59(9): 2198-2208.
38. Zhang DM, Chai Y, Erickson JR, Heller Brown J, Bers DM, Lin YF. Modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide via sGC/PKG/ROS/ERK1/2/CaMKII signaling in ventricular cardiomyocytes. J Physiol. 2014;592(pt 5):971-990.
39. Olsen HL, Theander S, Bokvist K, Buschard K, Wollheim CB, Gromada J. Glucose stimulates glucagon release in single rat α-cells by mechanisms that mirror the stimulus-secretion coupling in β-cells. Endocrinology. 2005;146(11):4861-4870.
40. Jacobson DA, Wicksteed BL, Philipson LH. The α-cell conundrum: ATP-sensitive K+ channels and glucose sensing. Diabetes. 2009; 58(2):304-306.
41. Dorrell C, Schug J, Lin CF, et al. Transcriptomes of the major human pancreatic cell types. Diabetologia. 2011;54(11):2832- 2844.
42. Spigelman AF, Dai X, MacDonald PE. Voltage-dependent K(+) channels are positive regulators of α cell action potential generation and glucagon secretion in mice and humans. Diabetologia. 2010; 53(9):1917-1926.
43. Kreneisz O, Benoit JP, Bayliss DA, Mulkey DK. AMP-activated protein kinase inhibits TREK channels. J Physiol. 2009;587(pt 24): 5819-5830.
44. Buckler KJ, Williams BA, Orozco RV, Wyatt CN. The role of TASK-like K+ channels in oxygen sensing in the carotid body. Novartis Found Symp. 2006;272:73-85; discussion 85-94, 131- 140.
45. De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab. 2010;11(6):543-553.
46. Olschewski A, Li Y, Tang B, et al. Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res. 2006;98(8):1072- 1080.
47. Ma L, Zhang X, Zhou M, Chen H. Acid-sensitive TWIK and TASK two-pore domain potassium channels change ion selectivity and become permeable to sodium in extracellular acidification. J Biol Chem. 2012;287(44):37145-37153.
48. Gelling RW, Du XQ, Dichmann DS, et al. Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA. 2003;100(3): 1438-1443.
49. Longuet C, Robledo AM, Dean ED, et al. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor. Diabetes. 2013;62(4): 1196-1205.
50. Cho YS, Chen CH, Hu C, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2012;44(1):67-72.
51. Mathie A, Veale EL. Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs. 2007;8(7):555-562.